Matthew Beckett

Dr. Matthew Beckett

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2021 in Journal of Cancer Policy
Verified
Journal Article
Open access
MBMatthew Beckett
Matthew Beckett
KCKatherine Cole
Katherine Cole
MWMitchell White
Mitchell White
JCJessica Chan
Jessica Chan
JMJason McVicar
Jason McVicar
JBJean-Marc Bourque
Jean-Marc Bourque
Cancer incidence and mortality among Indigenous peoples of Canada (First Nations, Inuit, and Métis) continue to rise in contrast to non-Indigenous Canadians, and Indigenous peoples are at higher risk of cancers associated with known modifiable risk factors. Jurisdictional and administrative challenges have hindered high quality cancer care for Indigenous peoples since the country's inception, and different Indigenous populations face these challenges under similar yet non-identical circumstances. Collaborative initiatives under Indigenous leadership have drawn attention to specific issues such as screening, funding, and culturally appropriate care, and have identified resources necessary to address these problems. The Canadian Partnership Against Cancer and their collaborators have committed significant resources to Indigenous cancer programs with locally and regionally determined leadership and priorities. In the context of broader global movements against systemic racism and inequity, decolonization of cancer care demands critical analysis of the existing cancer systems and restructuring under Indigenous leadership with multidisciplinary collaboration.

1 September 2023 in JCO Global Oncology
Verified
Journal Article
Open access
MBMatthew Beckett
Matthew Beckett
LGLuc Goethals
Luc Goethals
RKRyan D. Kraus
Ryan D. Kraus
KDKseniya Denysenko
Kseniya Denysenko
MGMaria Fernanda Barone Mussalem Gentiles
Maria Fernanda Barone Mussalem Gentiles
MAMay Abdel-Wahab
May Abdel-Wahab
Toward further understanding of the geographic disparities in oncologic outcomes faced by American patients.

16 February 2023 in Head & Neck
Verified
Journal Article
Open access
MBMatthew Beckett
Matthew Beckett
MGMarc Gaudet
Marc Gaudet
JBJean‐Marc Bourque
Jean‐Marc Bourque
KDKristopher Dennis
Kristopher Dennis
MAMay Abdel‐Wahab
May Abdel‐Wahab
BackgroundNot all patients with locally advanced head and neck cancer (HNC) who are eligible for adjuvant radiotherapy (RT) following upfront surgery appear to receive it. MethodsData were obtained from the Surveillance, Epidemiology, and End Results (SEER) database. Selected patients from 2009 to 2018 had locally advanced HNC, underwent upfront surgery, and were eligible for adjuvant RT. Multivariable logistic regression and chi-squared test were used to analyze available patient and tumor characteristics. ResultsOf 12 549 patients, 84.5% underwent adjuvant RT, 15.5% did not. Characteristics associated with lowest adjuvant RT utilization included cancers of the larynx (p < 0.0001) and gingivae (p < 0.0001), age 80 and above (p < 0.0001), unpartnered status (p < 0.0001), and residence within a nonmetropolitan area (p < 0.0024). ConclusionsTumor subsite, age, partnered status, and rural/urban residence correlate with omission of adjuvant RT in locally advanced HNC.

1 November 2024 in JCO Global Oncology
Verified
Journal Article
Open access
MBMatthew Beckett
Matthew Beckett
MBMustafa Al Balushi
Mustafa Al Balushi
JCJessica Chan
Jessica Chan
VIViktor Iakovenko
Viktor Iakovenko
MRMichael Roumeliotis
Michael Roumeliotis
JBJean Marc Bourque
Jean Marc Bourque
PURPOSE: Canadian radiation oncology professionals have a strong history of involvement in global oncology initiatives worldwide. This pan-Canadian survey-based study was conducted to determine the current level of engagement of Canadian radiation oncologists (ROs) and medical physicists (MPs) in global oncology initiatives and broaden the development of these activities. MATERIALS AND METHODS: This was a cross-sectional study. The survey was designed to characterize current levels of engagement of Canadian ROs and MPs in global oncology initiatives. The survey was open from March 2019 to April 2020. It was disseminated to all Canadian Association of Radiation Oncology and Canadian Organization of Medical Physicists members with two subsequent email reminders. RESULTS: Survey responses were received from 40 (93%) of the 43 Canadian cancer treatment centers that offer radiotherapy. At least one RO responded at 34 centers (79%) and one MP from 34 centers (79%) with some overlap. A response was received from a total of 93 participants, 47 ROs and 46 MPs. Of all survey participants, 58% reported some experience with global oncology. Nineteen percent of the participants surveyed were currently directly involved in short- or long-term projects, more than half of which have opportunity for additional staff involvement. The projects spanned 26 countries in South America, Africa, and Asia. Quality improvement and capacity building accounted for 27% and 20% of initiatives, respectively. The most common area of engagement was in direct treatment care, accounting for 56% of the projects. CONCLUSION: This study demonstrates the landscape of involvement of Canadian ROs and MPs in global oncology initiatives. The study also highlights areas of opportunity for broadening international participation and collaboration as it relates to global oncology for Canadian radiation oncology professionals.